Annual EBITDA
$818.24M$331.90M+68.25%
Summary
- Current Value
- As of today, GMED annual EBITDA is $818.24M, up +68.25% on
- Historical Performance
- GMED annual EBITDA is up +168.58% over the past 3 years, up +303.54% over the past 5 years
- All-Time High Comparison
- GMED annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- GMED annual EBITDA is +168.58% above its 3-year low of $304.65M reached on an earlier date
- Sector Comparison
- GMED annual EBITDA is higher than 92.76% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $818.24M | +68.3% | +168.6% | +303.5% | +674.4% | |
| Quarterly EBITDA | $233.43M | +42.1% | +207.7% | +224.7% | +759.9% | |
| TTM EBITDA | $887.38M | +56.8% | +181.7% | +284.0% | +3168.8% | |
| Price | $85.10 | +42.8% | +60.8% | +18.6% | – | |
| PE Ratio | 19.82 | -55.5% | -26.3% | -67.1% | – | |
| Annual Revenue | $2.94B | +16.6% | +187.3% | +272.5% | +919.8% | |
| Annual EPS | $3.92 | +425.4% | +111.8% | +287.4% | +554.1% | |
| $540.76M | +132.8% | +128.8% | +286.6% | +497.7% | ||
| Annual Net Income | $537.87M | +422.3% | +182.8% | +425.9% | +887.7% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $818.24M | at high | |
| 5Y | $818.24M | at high | |
| All | $818.24M | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $304.65M | N/A | +168.6% |
| 5Y | $202.76M | N/A | +303.5% |
| All | $97.30M | +741.0% |
EBITDA History
FAQ
What is the current annual EBITDA of GMED?
As of today, GMED annual EBITDA is $818.24M
What is 1-year change in GMED annual EBITDA?
GMED annual EBITDA is up +68.25% year-over-year
What is 3-year change in GMED annual EBITDA?
GMED annual EBITDA is up +168.58% over the past 3 years
How far is GMED annual EBITDA from its all-time high?
GMED annual EBITDA is currently at its all-time high
How does GMED annual EBITDA rank versus sector peers?
GMED annual EBITDA is higher than 92.76% of companies in Healthcare sector
When is GMED next annual earnings release?
As of today, the next annual earnings release for GMED has not been scheduled
Quarterly EBITDA
$233.43M$17.85M-7.10%
Summary
- Current Value
- As of today, GMED quarterly EBITDA is $233.43M, down -7.10% on
- Historical Performance
- GMED quarterly EBITDA is up +42.08% year-over-year, up +207.66% over the past 3 years
- All-Time High Comparison
- GMED quarterly EBITDA is currently -7.10% below its historical high of $251.28M set on
- 3-Year Low Comparison
- GMED quarterly EBITDA is +207.66% above its 3-year low of $75.87M reached on an earlier date
- Sector Comparison
- GMED quarterly EBITDA is higher than 92.51% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $233.43M | -7.1% | +42.1% | +207.7% | +224.7% | |
| Annual EBITDA | $818.24M | – | +68.3% | +168.6% | +303.5% | |
| TTM EBITDA | $887.38M | +8.4% | +56.8% | +181.7% | +284.0% | |
| Price | $85.10 | -10.8% | +42.8% | +60.8% | +18.6% | |
| PE Ratio | 19.82 | -18.3% | -55.5% | -26.3% | -67.1% | |
| Quarterly Revenue | $759.85M | -8.1% | +27.0% | +174.6% | +234.2% | |
| Quarterly EPS | $0.90 | -12.6% | +66.6% | +87.1% | +103.2% | |
| $163.57M | -9.9% | +66.5% | +183.2% | +198.9% | ||
| Quarterly Net Income | $124.30M | -11.6% | +64.7% | +153.0% | +174.2% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $251.28M | -7.1% | |
| 3Y | $251.28M | -7.1% | |
| 5Y | $251.28M | -7.1% | |
| All | $251.28M | -7.1% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $164.29M | N/A | +42.1% |
| 3Y | $75.87M | N/A | +207.7% |
| 5Y | $65.55M | +256.1% | |
| All | $14.19M | +1544.9% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of GMED?
As of today, GMED quarterly EBITDA is $233.43M
What is GMED quarterly EBITDA most recent change?
GMED quarterly EBITDA was down -7.10% on March 31, 2026
What is 1-year change in GMED quarterly EBITDA?
GMED quarterly EBITDA is up +42.08% year-over-year
How far is GMED quarterly EBITDA from its all-time high?
GMED quarterly EBITDA is currently -7.10% below its historical high of $251.28M set on December 31, 2025
How does GMED quarterly EBITDA rank versus sector peers?
GMED quarterly EBITDA is higher than 92.51% of companies in Healthcare sector
When is GMED next earnings release?
The next earnings release for GMED is on
TTM EBITDA
$887.38M$69.14M+8.45%
Summary
- Current Value
- As of today, GMED TTM EBITDA is $887.38M, up +8.45% on
- Historical Performance
- GMED TTM EBITDA is up +56.82% year-over-year, up +181.73% over the past 3 years
- All-Time High Comparison
- GMED TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- GMED TTM EBITDA is +181.73% above its 3-year low of $314.98M reached on an earlier date
- Sector Comparison
- GMED TTM EBITDA is higher than 92.69% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $887.38M | +8.4% | +56.8% | +181.7% | +284.0% | |
| Annual EBITDA | $818.24M | – | +68.3% | +168.6% | +303.5% | |
| Quarterly EBITDA | $233.43M | -7.1% | +42.1% | +207.7% | +224.7% | |
| Price | $85.10 | -10.8% | +42.8% | +60.8% | +18.6% | |
| PE Ratio | 19.82 | -18.3% | -55.5% | -26.3% | -67.1% | |
| TTM Revenue | $3.10B | +5.5% | +23.5% | +190.1% | +275.5% | |
| TTM EPS | $4.29 | +9.1% | +221.2% | +118.1% | +260.5% | |
| $606.12M | +12.1% | +101.4% | +146.9% | +266.0% | ||
| TTM Net Income | $586.71M | +9.1% | +216.2% | +191.6% | +382.2% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $887.38M | at high | |
| 3Y | $887.38M | at high | |
| 5Y | $887.38M | at high | |
| All | $887.38M | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $565.84M | N/A | +56.8% |
| 3Y | $314.98M | N/A | +181.7% |
| 5Y | $231.07M | N/A | +284.0% |
| All | $27.15M | +3168.8% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of GMED?
As of today, GMED TTM EBITDA is $887.38M
What is GMED TTM EBITDA most recent change?
GMED TTM EBITDA was up +8.45% on March 31, 2026
What is 1-year change in GMED TTM EBITDA?
GMED TTM EBITDA is up +56.82% year-over-year
How far is GMED TTM EBITDA from its all-time high?
GMED TTM EBITDA is currently at its all-time high
How does GMED TTM EBITDA rank versus sector peers?
GMED TTM EBITDA is higher than 92.69% of companies in Healthcare sector
When is GMED next earnings release?
The next earnings release for GMED is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- GMED Official Website www.globusmedical.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1237831/000162828026011209/0001628280-26-011209-index.htm
- GMED Profile on Yahoo Finance finance.yahoo.com/quote/GMED
- GMED Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gmed